Opioid Crisis in the US – Lessons from Western Europe

Abstract

View all access options for this article.

M.D.

Volkow , and

A.T.

McLellan , “Opioid Abuse in Chronic Pain — Misconceptions and Mitigation Strategies,” New England Journal of Medicine 374 (2016): 1253–1263.

Sarpatwari ,

M.S.

Sinha , and

A.S.

Kesselheim , “The Opioid Epidemic: Fixing a Broken Pharmaceutical Market,” Harvard Law and Policy Review 11, no. 2 (2017):463–484.

van Amsterdam and

van den Brink , “The Misuse of Prescription Opioids: A Threat for Europe?” Current Drug Abuse Review 8, no. 1 (2015): 3–14.

Sarpatwari ,

M.S.

Sinha , and

A.S.

Kesselheim , “The Opioid Epidemic: Fixing a Broken Pharmaceutical Market,” Harvard Law and Policy Review 11, no. 2 (2017): 463–484.

Federal Office for Public Health. supra note 4.

Federal Office for Public Health, supra note 4.

10.

M. S.

Sinha ,

A. S.

Kesselheim ,

J. J.

Darrow , “Pharmaceutical Advertising in Medical Journals Revisiting a Long Standing Relationship,” CHEST 153, no. 1 (2018): 9-11.

11.

A. Sarpatwari et al., supra note 2.

12.

Art. 33(1) Federal Act on Medicinal Products and Medical Devices.

13.